Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 150 entries
Sorted by: Best Match Show Resources per page
Adoption of Sacubitril/Valsartan Must Take Into Account Different Heart Failure Patient Types.

JACC. Heart failure

Di Tano G, Bettari L.
PMID: 28859758
JACC Heart Fail. 2017 Sep;5(9):688-689. doi: 10.1016/j.jchf.2017.06.011.

No abstract available.

Correction.

JACC. Heart failure

[No authors listed]
PMID: 28359423
JACC Heart Fail. 2017 Apr;5(4):316. doi: 10.1016/j.jchf.2017.02.006.

No abstract available.

Greatness.

JACC. Heart failure

Godwin J.
PMID: 29284581
JACC Heart Fail. 2018 Jan;6(1):80-81. doi: 10.1016/j.jchf.2017.09.016.

No abstract available.

Correction.

JACC. Heart failure

[No authors listed]
PMID: 29957198
JACC Heart Fail. 2018 Jul;6(7):617. doi: 10.1016/j.jchf.2018.05.010.

No abstract available.

Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper.

JACC. Heart failure

Ibrahim NE, Burnett JC, Butler J, Camacho A, Felker GM, Fiuzat M, O'Connor C, Solomon SD, Vaduganathan M, Zile MR, Januzzi JL.
PMID: 32171762
JACC Heart Fail. 2020 May;8(5):347-358. doi: 10.1016/j.jchf.2019.12.010. Epub 2020 Mar 11.

This study investigated the use of natriuretic peptides as inclusion criteria and to develop recommendations regarding their use. B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are commonly used as inclusion criteria for heart failure (HF) clinical...

Look After You Leap.

JACC. Heart failure

Whellan DJ.
PMID: 34857176
JACC Heart Fail. 2021 Dec;9(12):925-926. doi: 10.1016/j.jchf.2021.09.003.

No abstract available.

The Challenges of NT-proBNP Testing in HFpEF: Shooting Arrows in the Wind.

JACC. Heart failure

Januzzi JL, Myhre PL.
PMID: 32241618
JACC Heart Fail. 2020 May;8(5):382-385. doi: 10.1016/j.jchf.2020.03.003. Epub 2020 Mar 30.

No abstract available.

Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes.

JACC. Heart failure

Khan MS, Solomon N, DeVore AD, Sharma A, Felker GM, Hernandez AF, Heidenreich PA, Matsouaka RA, Green JB, Butler J, Yancy CW, Peterson PN, Fonarow GC, Greene SJ.
PMID: 34895861
JACC Heart Fail. 2021 Nov 30; doi: 10.1016/j.jchf.2021.11.001. Epub 2021 Nov 30.

OBJECTIVES: The authors sought to characterize associations between initiation of metformin and sulfonylurea therapy and clinical outcomes among patients with comorbid heart failure (HF) and diabetes (overall and by ejection fraction [EF] phenotype).BACKGROUND: Metformin and sulfonylureas are frequently prescribed...

To 'Plant or Not to 'Plant, That Is the Question.

JACC. Heart failure

Esto R.
PMID: 34969499
JACC Heart Fail. 2022 Jan;10(1):65-66. doi: 10.1016/j.jchf.2021.10.011.

No abstract available.

Classifying Heart Failure in the 21st Century: Matching Taxonomy With Science.

JACC. Heart failure

Greenberg B, O'Connor CM, Felker GM.
PMID: 34593202
JACC Heart Fail. 2021 Oct;9(10):771-773. doi: 10.1016/j.jchf.2021.08.004.

No abstract available.

Neprilysin Inhibition in the Time of Precision Medicine.

JACC. Heart failure

Feldman AM.
PMID: 27107556
JACC Heart Fail. 2016 Apr 12; doi: 10.1016/j.jchf.2016.02.016. Epub 2016 Apr 12.

No abstract available.

What Can We Learn From Norway?: Income and Education Matter, Even Under Universal Health Care.

JACC. Heart failure

Allen LA, Swat SA.
PMID: 33039445
JACC Heart Fail. 2020 Nov;8(11):928-930. doi: 10.1016/j.jchf.2020.08.011. Epub 2020 Oct 07.

No abstract available.

Showing 1 to 12 of 150 entries